Skip to main content
. 2014 Sep 15;35(10):1257–1264. doi: 10.1038/aps.2014.75

Figure 4.

Figure 4

Liguzinediol decreases the ratio of Bax/Bcl-2 in cardiomyocytes. (A) Bax and Bcl-2 protein expression as determined by Western blot assays. (B) SDS/PAGE analysis shows changes in Bax and Bcl-2 protein expression. bP<0.05, cP<0.01 vs the control group. eP<0.05, fP<0.01 vs the DOX group (n=3). (C) SDS/PAGE analysis shows the ratio of Bax to Bcl-2 protein expression. bP<0.05, cP<0.01 vs the control group. eP<0.05, fP<0.01 vs the DOX group (n=3).